Biomerica (BMRA)
(Delayed Data from NSDQ)
$0.32 USD
-0.02 (-5.56%)
Updated Oct 15, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Biomerica, Inc falls in the month of May.
All items in Millions except Per Share data.
5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 4 | 10 | 6 | 4 | 9 |
Receivables | 1 | 1 | 1 | 1 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 2 | 2 | 3 | 3 |
Other Current Assets | 0 | 0 | 0 | 0 | 2 |
Total Current Assets | 8 | 13 | 9 | 9 | 15 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 9 | 14 | 11 | 12 | 17 |
Liabilities & Shareholders Equity | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1 | 1 | 1 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2 | 2 | 2 | 1 | 1 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3 | 3 | 3 | 3 | 3 |
Shareholders Equity | 5/31/2024 | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 54 | 53 | 42 | 37 | 35 |
Retained Earnings | -48 | -42 | -35 | -28 | -22 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 7 | 12 | 8 | 9 | 14 |
Total Liabilities & Shareholder's Equity | 9 | 14 | 11 | 12 | 17 |
Total Common Equity | 7 | 12 | 8 | 9 | 14 |
Shares Outstanding | 16.80 | 16.80 | 12.80 | 12.30 | 9.80 |
Book Value Per Share | 0.39 | 0.70 | 0.65 | 0.75 | 1.45 |
Fiscal Year End for Biomerica, Inc falls in the month of May.
All items in Millions except Per Share data.
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 4 | 5 | 7 | 8 |
Receivables | NA | 1 | 1 | 1 | 1 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 2 | 2 | 2 | 2 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 8 | 9 | 10 | 12 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 9 | 10 | 12 | 13 |
Liabilities & Shareholders Equity | 8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 1 | 1 | 1 | 1 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 1 | 1 | 1 | 1 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 2 | 2 | 2 | 2 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 3 | 3 | 2 | 2 |
Shareholders Equity | 8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 54 | 53 | 53 | 53 |
Retained Earnings | NA | -48 | -47 | -45 | -43 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 7 | 8 | 9 | 11 |
Total Liabilities & Shareholder's Equity | NA | 9 | 10 | 12 | 13 |
Total Common Equity | 0 | 7 | 8 | 9 | 11 |
Shares Outstanding | 16.80 | 16.80 | 16.80 | 16.80 | 15.50 |
Book Value Per Share | 0.00 | 0.39 | 0.46 | 0.56 | 0.69 |